EPAM vs TECH · P/E 14, rev $4.73B vs P/E 65, rev $1.22B
EPAM Systems Inc (EPAM) versus Bio-Techne Corp (TECH) — a side-by-side from cached financials, not a winner call.
EPAM Systems Inc (EPAM) is a information technology services company listed on US.
Bio-Techne Corp (TECH) is a biotechnology company listed on US.
Latest reported EPAM revenue for 2024-12-31 was $4.73B. Net income was $454.5M. Revenue was up 0.8% from 2023-12-31 to 2024-12-31. EPAM currently screens at market cap $5.10B and trailing P/E 14.0.
Latest reported TECH revenue for 2025-06-30 was $1.22B. Net income was $73.4M. Revenue was up 5.2% from 2024-06-30 to 2025-06-30. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
EPAM currently screens at market cap $5.10B and trailing P/E 14.0. TECH currently screens at market cap $8.49B and trailing P/E 65.2.
Not investment advice. Open the EPAM and TECH stock pages for the full models.
Not investment advice.